Atsushi Kumanogoh Selected Research

Atsushi Kumanogoh Research Topics

Disease

69	Neoplasms (Cancer) 04/2024 - 01/2007
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2012
24	Rheumatoid Arthritis 07/2023 - 01/2012
22	Inflammation (Inflammations) 01/2024 - 04/2007
19	COVID-19 04/2023 - 01/2021
11	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2013
11	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 08/2002
10	Fibrosis (Cirrhosis) 01/2024 - 07/2012
9	Arthritis (Polyarthritis) 01/2023 - 01/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2008
8	Multiple Sclerosis 08/2021 - 08/2008
7	Disease Progression 01/2024 - 01/2014
7	Pneumonia (Pneumonitis) 11/2023 - 01/2013
6	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2011
6	Infections 01/2023 - 01/2020
6	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 10/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 04/2012
6	Leukemia 01/2016 - 12/2012
5	Hypoxia (Hypoxemia) 01/2024 - 05/2015
5	Hypersensitivity (Allergy) 01/2023 - 07/2009
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 03/2009
5	Emphysema 01/2022 - 10/2013
4	Rhinosinusitis 03/2024 - 01/2019
4	Asthma (Bronchial Asthma) 03/2024 - 01/2013
4	Idiopathic Pulmonary Fibrosis 01/2024 - 01/2014
4	Systemic Scleroderma (Systemic Sclerosis) 09/2023 - 01/2015
4	Rheumatic Diseases (Rheumatism) 07/2023 - 01/2018
4	Necrosis 01/2023 - 03/2009
4	Adenocarcinoma of Lung 01/2022 - 01/2012
4	Psoriatic Arthritis 05/2021 - 01/2012
4	Fever (Fevers) 05/2021 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2012
4	Vasculitis (Vasculitides) 01/2020 - 08/2017
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 08/2017
4	Carcinogenesis 11/2016 - 06/2006
3	Bites and Stings (Sting) 04/2024 - 10/2018
3	Sepsis (Septicemia) 08/2023 - 01/2022
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2022 - 01/2013
3	Idiopathic Interstitial Pneumonias 01/2022 - 10/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2011
3	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 11/2014
3	Lung Diseases (Lung Disease) 01/2021 - 01/2013
3	Colitis 01/2021 - 02/2012
3	Osteoporosis 01/2021 - 03/2013
3	Pulmonary Hypertension 01/2021 - 05/2015
3	Bone Resorption 01/2021 - 01/2011
3	Pulmonary Alveolar Proteinosis 01/2021 - 11/2014

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2010
20	Semaphorins (Semaphorin)IBA 02/2024 - 06/2006
20	Peptides (Polypeptides)IBA 01/2023 - 08/2002
18	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2016
17	Immune Checkpoint InhibitorsIBA 04/2024 - 08/2018
16	AntigensIBA 01/2022 - 04/2007
13	VaccinesIBA 03/2023 - 02/2014
12	CD100 antigenIBA 01/2020 - 01/2007
10	AutoantibodiesIBA 02/2022 - 03/2009
9	Immunoglobulin G (IgG)IBA 03/2023 - 03/2009
9	CytokinesIBA 01/2017 - 04/2007
8	AntibodiesIBA 01/2023 - 04/2016
8	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2018
8	Protein Subunit VaccinesIBA 01/2022 - 07/2015
7	InterferonsIBA 04/2024 - 12/2012
7	EpitopesIBA 01/2023 - 12/2012
7	Monoclonal AntibodiesIBA 01/2022 - 10/2002
6	NivolumabIBA 04/2024 - 10/2018
6	GlucocorticoidsIBA 01/2024 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2020
6	Messenger RNA (mRNA)IBA 01/2023 - 07/2015
6	TetraspaninsIBA 01/2020 - 07/2012
6	WT1 ProteinsIBA 11/2018 - 03/2012
5	Therapeutic UsesIBA 01/2024 - 01/2017
5	Janus Kinase InhibitorsIBA 07/2023 - 01/2020
5	SteroidsIBA 04/2023 - 01/2017
5	Cancer VaccinesIBA 01/2023 - 02/2014
5	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2017
5	tocilizumab (atlizumab)FDA Link 09/2020 - 01/2012
5	Interleukin-17 (Interleukin 17)IBA 03/2020 - 05/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2004
4	Granzymes (Granzyme)IBA 04/2024 - 04/2013
4	pembrolizumabIBA 01/2024 - 01/2019
4	ProteomeIBA 01/2024 - 12/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 01/2012
4	mRNA VaccinesIBA 03/2023 - 03/2022
4	HLA-A*24:02 antigenIBA 01/2023 - 12/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
4	LigandsIBA 01/2021 - 01/2019
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 11/2014
4	Myelin-Oligodendrocyte GlycoproteinIBA 04/2011 - 08/2002
3	Complement System Proteins (Complement)IBA 01/2024 - 03/2009
3	Mitochondrial DNA (mtDNA)IBA 10/2023 - 04/2018
3	Abatacept (Orencia)FDA Link 03/2023 - 09/2020
3	Neutralizing AntibodiesIBA 03/2023 - 04/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2020
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2013

Therapy/Procedure

32	Therapeutics 11/2023 - 05/2010
29	Immunotherapy 04/2024 - 05/2011
13	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
3	Chemoradiotherapy 05/2023 - 01/2019